5 Oversold Global Stocks To Buy

3. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)

Latest 14 Day RSI Score: 17.82

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) is an Israeli firm that focuses on developing treatments for people suffering from hepatitis and other liver diseases that are generally a result of other serious diseases such as HIV. The stock was in for some good news in July after receiving a Buy upgrade, but overall, analyst sentiment has waned over the years.

Insider Monkey dug through 943 hedge fund portfolios for their first quarter of 2023 shareholdings to discover that four had invested in Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD). Mark Lampert’s Biotechnology Value Fund / BVF Inc is the largest shareholder out of these, with a $574,818 stake.

Follow Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)